progesterone receptor antagonist

You have access
Long-term High-quality Survival with Single-agent Mifepristone Treatment Despite Advanced Cancer
JEROME H. CHECK, DIANE CHECK, CARRIE WILSON and PATRICE LOFBERG

Anticancer Research December 2016, 36 (12) 6511-6513;
You have access
Evidence that Mifepristone, a Progesterone Receptor Antagonist, Can Cross the Blood Brain Barrier and Provide Palliative Benefits for Glioblastoma Multiforme Grade IV
JEROME H. CHECK, CARRIE WILSON, RACHAEL COHEN and MOJIRAYO SARUMI

Anticancer Research May 2014, 34 (5) 2385-2388;

Main menu